Dear Doctor Letter (Rote-Hand-Brief) on Spinraza (nusinersen): communicating hydrocephalus not related to meningitis or bleeding reported
2018.07.31
Active substance: nusinersen
The marketing authorization holder, Biogen, informs of the occurrence of communicating hydrocephalus not related to meningitis or bleeding under treatment with Spinraza. Biogen informs on several measures that should be followed.
Download DHPC/Information letter , Download_VeroeffentlichtAm_EN